The Premier Sugar Mills & Distillery Company Limited (PSX:PMRS)

CTI BioPharma Balance Sheet

Financials in millions PKR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	1,390	1,115	950.61	337.85	501.49	364.71
Trading Asset Securities	-	0.08	10.31	25.24	34.7	31.1
Cash & Short-Term Investments	1,390	1,115	960.92	363.09	536.19	395.8
Cash Growth	61.70%	16.00%	164.65%	-32.28%	35.47%	15.96%
Accounts Receivable	1,431	440.45	1,251	89.23	690.42	159.93
Other Receivables	1,117	540.6	283.99	338.47	600.71	648.58
Receivables	3,945	981.05	1,535	427.7	1,291	808.51
Inventory	14,998	5,900	6,476	4,764	2,128	2,071
Prepaid Expenses	-	14.14	15.43	6.62	6.64	5.79
Other Current Assets	288.15	1,160	1,101	1,494	804.22	1,419
Total Current Assets	20,621	9,170	10,089	7,055	4,766	4,700
Property, Plant & Equipment	25,522	29,975	27,125	21,625	15,003	12,337
Long-Term Investments	179.73	203.92	182.47	172	160.38	163.58
Long-Term Deferred Tax Assets	487.65	192.1	10.1	-	-	-
Other Long-Term Assets	36.94	37.33	41.53	42.42	41.56	42.18
Total Assets	46,847	39,578	37,447	28,895	19,970	17,242
Accounts Payable	4,148	765.63	559.73	342.75	369.28	564.99
Accrued Expenses	991.66	1,191	1,436	823.24	381.44	444.31
Short-Term Debt	20,426	9,672	4,616	5,003	2,678	2,670
Current Portion of Long-Term Debt	-	1,464	1,337	804.5	741.57	515.85
Current Portion of Leases	-	92.06	92.01	90.4	102.39	95.81
Current Income Taxes Payable	635.06	418.54	129.13	18.24	16.73	24.18
Current Unearned Revenue	228.01	36.54	1,975	233.5	3.01	3.95
Other Current Liabilities	1,347	717.63	366.99	310.14	168.16	202.09
Total Current Liabilities	27,776	14,357	10,512	7,626	4,461	4,522
Long-Term Debt	3,642	6,419	4,830	4,374	1,905	1,757
Long-Term Leases	196.66	165.81	161.4	146.6	227.98	280.96
Long-Term Unearned Revenue	32.97	49.7	76.28	0.42	27.49	41.84
Long-Term Deferred Tax Liabilities	-	3,241	4,003	3,281	1,864	1,466
Total Liabilities	32,763	24,298	19,643	15,471	8,517	8,095
Common Stock	37.5	37.5	37.5	37.5	37.5	37.5
Retained Earnings	2,653	1,296	3,353	2,234	2,201	2,201
Comprehensive Income & Other	4,557	5,929	5,805	4,564	3,874	2,780
Total Common Equity	7,247	7,263	9,196	6,835	6,113	5,018
Minority Interest	6,836	8,017	8,609	6,589	5,340	4,129
Shareholders' Equity	14,083	15,280	17,805	13,424	11,453	9,147
Total Liabilities & Equity	46,847	39,578	37,447	28,895	19,970	17,242
Total Debt	24,265	17,814	11,036	10,418	5,655	5,320
Net Cash (Debt)	-22,875	-16,699	-10,076	-10,055	-5,119	-4,924
Net Cash Per Share	-	-4453.03	-2686.82	-2681.32	-1365.10	-1313.10
Filing Date Shares Outstanding	-	3.75	3.75	3.75	3.75	3.75
Total Common Shares Outstanding	-	3.75	3.75	3.75	3.75	3.75
Working Capital	-7,155	-5,187	-423.32	-570.72	305.21	178.37
Book Value Per Share	-	1936.71	2452.26	1822.60	1630.05	1338.19
Tangible Book Value	7,247	7,263	9,196	6,835	6,113	5,018
Tangible Book Value Per Share	-	1936.71	2452.26	1822.60	1630.05	1338.19
Land	-	6,950	6,394	3,186	2,991	1,532
Buildings	-	5,048	3,250	3,066	2,462	2,227
Machinery	-	16,744	14,477	12,222	10,252	9,201
Construction In Progress	-	2,054	3,543	3,802	529.22	820.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.